Thomas J. FitzGerald

UMass Memorial Medical Center

Dr. FitzGerald is the Professor and Chair of the Department of Radiation Oncology at the University of Massachusetts Medical School. The department has a strong academic mission and provides clinical care to multiple communities throughout central Massachusetts with several community centers providing advanced technology clinical care. Dr. FitzGerald has been Principal Investigator of the Quality Assurance Review Center (QARC) for more than 25 years. QARC provides imaging and radiation oncology data acquisition and data management service to the National Clinical Trials Network (NCTN) and industry partners. QARC is now part of the Imaging and Radiation Oncology Core (IROC), which centralizes data management and quality assurance service for NCTN clinical trials with offices in Rhode Island, Houston, TX, Columbus, OH, and Philadelphia, PA. In this capacity, proton institution applications are credentialed for clinical trial participation and data are reviewed for protocol compliance. Dr. FitzGerald serves in an advisory capacity for The Cancer Imaging Archive (TCIA).

1books edited

7chapters authored

Latest work with IntechOpen by Thomas J. FitzGerald

Over the past twenty-five years, proton therapy has become more prominent worldwide. It is an important component of clinical radiation therapy for both adult and pediatric clinical care. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. As such, Proton Therapy - Current Status and Future Directions reviews many aspects of proton care including the application of protons in modern clinical trials. It also reviews problems associated with the migration of proton care worldwide and examines the future direction of proton care. This project was created by colleagues at IntechOpen and was carefully managed by Romina Rovan. It has been a privilege to help coordinate the text and chapters designed to acknowledge the history, footprint, and growing interest of proton care worldwide. Proton management is now embedded in the clinical trials process. In pediatric care, proton delivery is embedded with photons for the management of pediatric malignancies and adult groups have initiated proton-specific clinical trials. A proton registry has been established and outcomes are under evaluation. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology.

Go to the book